IRulya Therapeutics Inc. (IRLA)
NASDAQ: IRLA · Real-Time Price · USD
33.08
+0.25 (0.76%)
Oct 23, 2026, 4:00 PM EDT - Market closed
IRulya Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Initiates $72 | Buy | Initiates | $72 | +117.65% | Oct 9, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $98 | Buy | Maintains | $98 | +196.25% | Sep 30, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $68 | Buy | Reiterates | $68 | +105.56% | Sep 30, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $68 | Buy | Maintains | $68 | +105.56% | Sep 30, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $70 | Buy | Initiates | $70 | +111.61% | Sep 24, 2026 |
| Citizens JMP | Citizens JMP | Buy Upgrades $77 | Buy | Upgrades | $77 | +132.77% | Sep 22, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $80 → $70 | Buy | Reiterates | $80 → $70 | +111.61% | Aug 18, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $82 | Buy | Reiterates | $82 | +147.88% | Aug 17, 2026 |